Inventor
JANTZ DEREK
US58 patents
⚠️ This page may combine multiple inventors who share the name “JANTZ DEREK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PREC BIOSCIENCES INC
31 patentsUS10041053B2Aug 7, 2018
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
PREC BIOSCIENCES INC43 citations98
US9889160B2Feb 13, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC65 citations98
US9434931B2Sep 6, 2016
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
PREC BIOSCIENCES INC63 citations98
US9340777B2May 17, 2016
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
PREC BIOSCIENCES INC49 citations98
US9889161B2Feb 13, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC27 citations97
US10093900B2Oct 9, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC15 citations92
US10093899B1Oct 9, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC8 citations92
US9993502B1Jun 12, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC16 citations92
US9993501B2Jun 12, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC11 citations92
US9969975B1May 15, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC13 citations92
US9950010B1Apr 24, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC14 citations92
US9950011B1Apr 24, 2018
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC14 citations92
US10851358B2Dec 1, 2020
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
PREC BIOSCIENCES INC11 citations86
US10799535B2Oct 13, 2020
Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC5 citations84
US10800833B2Oct 13, 2020
Co-stimulatory domains for use in genetically-modified cells
PREC BIOSCIENCES INC7 citations84
US10662416B2May 26, 2020
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
PREC BIOSCIENCES INC4 citations84
US10287626B2May 14, 2019
Recognition sequences for I-CreI-derived meganucleases and uses thereof
PREC BIOSCIENCES INC5 citations84
US10273524B2Apr 30, 2019
Recognition sequences for I-CreI-derived meganucleases and uses thereof
PREC BIOSCIENCES INC5 citations84
US9683257B2Jun 20, 2017
Recognition sequences for I-CreI-derived meganucleases and uses thereof
PREC BIOSCIENCES INC10 citations84
US11053484B2Jul 6, 2021
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
PREC BIOSCIENCES INC5 citations82
US11274285B2Mar 15, 2022
Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome
PREC BIOSCIENCES INC2 citations73
US10603363B2Mar 31, 2020
Treatment of retinitis pigmentosa using engineered meganucleases
PREC BIOSCIENCES INC3 citations73
US9822381B2Nov 21, 2017
Methods and products for producing engineered mammalian cell lines with amplified transgenes
PREC BIOSCIENCES INC2 citations73
US11680254B2Jun 20, 2023
Engineered meganucleases specific for recognition sequences in the PCSK9 gene
PREC BIOSCIENCES INC3 citations72
US11286291B2Mar 29, 2022
Co-stimulatory domains for use in genetically-modified cells
PREC BIOSCIENCES INC2 citations68
US12351839B2Jul 8, 2025
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
PREC BIOSCIENCES INC0 citations63
US12595469B2Apr 7, 2026
Treatment of retinitis pigmentosa using improved engineered meganucleases
PREC BIOSCIENCES INC0 citations62
US11266693B2Mar 8, 2022
Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC0 citations62
US11268065B2Mar 8, 2022
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
PREC BIOSCIENCES INC0 citations62
US11278632B2Mar 22, 2022
Engineered nucleases useful for treatment of hemophilia A
PREC BIOSCIENCES INC0 citations61
US12448613B2Oct 21, 2025
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
PREC BIOSCIENCES INC0 citations60
SMITH JAMES JEFFERSON
10 patentsUS8304222B1Nov 6, 2012
Rationally-designed meganucleases with altered sequence specificity and heterodimer formation
SMITH JAMES JEFFERSON80 citations99
US8163514B2Apr 24, 2012
Methods of cleaving DNA with rationally-designed meganucleases
SMITH JAMES JEFFERSON185 citations99
US8148098B2Apr 3, 2012
Methods of cleaving DNA with rationally-designed meganucleases
SMITH JAMES JEFFERSON88 citations99
US8143015B2Mar 27, 2012
Methods of cleaving DNA with rationally-designed meganucleases
SMITH JAMES JEFFERSON90 citations99
US8143016B2Mar 27, 2012
Methods of cleaving DNA with rationally-designed meganucleases
SMITH JAMES JEFFERSON89 citations99
US8133697B2Mar 13, 2012
Methods of cleaving DNA with rationally-designed meganucleases
SMITH JAMES JEFFERSON181 citations99
US8129134B2Mar 6, 2012
Methods of cleaving DNA with rationally-designed meganucleases
SMITH JAMES JEFFERSON180 citations99
US8124369B2Feb 28, 2012
Method of cleaving DNA with rationally-designed meganucleases
SMITH JAMES JEFFERSON173 citations99
US8119361B2Feb 21, 2012
Methods of cleaving DNA with rationally-designed meganucleases
SMITH JAMES JEFFERSON108 citations99
US8119381B2Feb 21, 2012
Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
SMITH JAMES JEFFERSON182 citations99
PIONEER HI BRED INT
3 patentsUS10822610B2Nov 3, 2020
Methods for producing a complex transgenic trait locus
PIONEER HI BRED INT4 citations84
US11459576B2Oct 4, 2022
Methods for producing a complex transgenic trait locus
PIONEER HI BRED INT2 citations73
US12338444B2Jun 24, 2025
Methods for producing a complex transgenic trait locus
PIONEER HI BRED INT0 citations62
UNIV DUKE
2 patentsUS8021867B2Sep 20, 2011
Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
UNIV DUKE304 citations98
US8377674B2Feb 19, 2013
Method for producing genetically-modified cells with rationally-designed meganucleases with altered sequence specificity
UNIV DUKE4 citations74
SMITH JAMES J
1 patentJANTZ DEREK
1 patentLASSNER MICHAEL
1 patentBIDNEY DENNIS
1 patentShowing the top 50 of 58 patents by PatentIndex Score.